Item Type | Name |
Academic Article
|
Treatment of chronic autoimmune urticaria with omalizumab.
|
Concept
|
Antibodies
|
Concept
|
Antibodies, Anti-Idiotypic
|
Concept
|
Antibodies, Monoclonal
|
Concept
|
Antibodies, Blocking
|
Academic Article
|
Structure-function correlation of human kininogen.
|
Academic Article
|
Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.
|
Academic Article
|
Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III.
|
Academic Article
|
Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine.
|
Academic Article
|
Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes.
|
Academic Article
|
Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma.
|
Academic Article
|
Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody.
|
Academic Article
|
Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity.
|
Academic Article
|
Recombinant human interleukin-1 beta causes histamine release from human basophils.
|
Academic Article
|
Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells.
|
Academic Article
|
Mediator release from basophil granulocytes in chronic myelogenous leukemia.
|
Academic Article
|
Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
|
Academic Article
|
Further characterization of histamine releasing chemokines present in fractionated supernatants derived from human mononuclear cells.
|
Academic Article
|
Antithyroid antibodies in chronic urticaria and angioedema.
|
Academic Article
|
Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells.
|
Academic Article
|
Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli.
|
Academic Article
|
Pathogenesis of chronic urticaria.
|
Academic Article
|
Pathogenesis and treatment of chronic urticaria.
|
Academic Article
|
Omalizumab is effective in nonautoimmune urticaria.
|
Academic Article
|
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
|
Academic Article
|
Biologic agents in the treatment of urticaria.
|
Academic Article
|
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
|
Academic Article
|
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
|
Academic Article
|
Therapy of chronic urticaria: a simple, modern approach.
|
Academic Article
|
The maddening itch: an approach to chronic urticaria.
|
Academic Article
|
Biologic agents and the therapy of chronic spontaneous urticaria.
|
Academic Article
|
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
|
Academic Article
|
Platelet glycoprotein Ib: a zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen.
|
Academic Article
|
Activation of the kinin-forming cascade on the surface of endothelial cells.
|
Concept
|
Antibodies, Monoclonal, Humanized
|
Academic Article
|
gC1qR Antibody Can Modulate Endothelial Cell Permeability in Angioedema.
|
Academic Article
|
An atypical case of idiopathic nonhistaminergic angioedema with anti-C1-INH antibodies.
|